Re: Magone et al.: Ocular adverse effects of infigratinib, a new fibroblast growth factor receptor tyrosine kinase inhibitor (Ophthalmology. 2021;128:624-626).

Overview

authors

Francis, Jasmine H.
Canestraro, Julia
Abramson, David H

publication date

June 21, 2021

published in

Ophthalmology Journal

Research

keywords

Phenylurea Compounds
Protein-Tyrosine Kinases

Identity

Scopus Document Identifier

85112335470

Digital Object Identifier (DOI)

10.1016/j.ophtha.2021.05.012

PubMed ID

34167830

Additional Document Info

volume

128

issue

9